Herbas VPB

Print
EN | LT
LT - ADENO-ASSOCIATED VIRUS FORMULATIONS
EN - ADENO-ASSOCIATED VIRUS FORMULATIONS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 15/86 (2006.01)
A61K 31/195 (2013.01)
A61K 35/76 (2015.01)
A61K 35/76 (2013.01)
A61P 7/00 (2018.01)
A61P 7/00 (2006.01)
A61K 9/0019 (2013.01)
A61K 9/00 (2006.01)
A61K 9/19 (2006.01)
A61K 9/19 (2013.01)
A61K 47/02 (2006.01)
A61K 47/183 (2013.01)
A61K 47/18 (2017.01)
A61K 47/22 (2013.01)
A61K 31/195 (2006.01)
A61K 47/26 (2013.01)
A61K 47/22 (2006.01)
A61K 47/02 (2013.01)
A61K 47/26 (2006.01)
A61K 47/18 (2013.01)
C12N 15/86 (2013.01)
European patent
(11) Number of the document 3534922
(13) Kind of document T
(96) European patent application number 17866366.2
Date of filing the European patent application 2017-11-03
(97) Date of publication of the European application 2019-09-11
(45) Date of publication and mention of the grant of the patent 2024-04-17
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/059971
Date 2017-11-03
PCT application publication
(87) Number WO 2018/128689
Date 2018-07-12
Priority applications
(30) Number Date Country code
201662417750 P 2016-11-04 US
Inventors
(72)
FIEDLER, Christian , AT
FRITSCHER, Eva , AT
HASSLACHER, Meinhard , AT
MITTERGRADNEGGER, Dominik , AT
TABISH, Tanvir , AT
Grantee
(73) Takeda Pharmaceutical Company Limited , 1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, JP
Title
(54) ADENO-ASSOCIATED VIRUS FORMULATIONS
  ADENO-ASSOCIATED VIRUS FORMULATIONS